Format

Send to

Choose Destination
Curr Neurol Neurosci Rep. 2001 May;1(3):238-44.

Immunologic approaches to therapy for brain tumors.

Author information

1
Department of Immunology, University of Colorado Health Sciences Center, 4200 E. Ninth Avenue, Denver, CO 80262, USA.

Abstract

Malignant brain tumors are notoriously invasive. Although surgical debulking can relieve the patient of the main mass of tumor, adjuvant treatments are needed to target the glioma cells that infiltrate through normal parenchyma as single cells or pockets of tumor cells from which recurrent tumors arise. Successful adjuvant cellular therapy of brain tumors, or activation of endogenous immune cells, requires that either cell effectors make direct contact with tumor cells or come within close proximity to them and exert an indirect effect. This review examines current clinical trials aimed at direct lysis of glioma cells and trials making gliomas more visible to the endogenous immune system.

PMID:
11898524
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center